vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与TELOS CORP（TLS）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是TELOS CORP的1.6倍（$75.5M vs $46.8M），TELOS CORP同比增速更快（77.4% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $8.0M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 25.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
泰洛斯公司（Telos Corporation）是一家信息技术与网络安全企业，总部位于美国弗吉尼亚州阿什本。公司主要服务对象为政府与企业客户，业务合同大部分来自美国国防部，核心客户涵盖美国军方、情报机构、民政部门以及北约盟友机构。
PBYI vs TLS — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$46.8M
营收增速更快
TLS
高出49.7%
27.7%
自由现金流更多
PBYI
多$6.4M
$8.0M
两年增速更快
PBYI
近两年复合增速
25.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $46.8M |
| 净利润 | — | $-16.3M |
| 毛利率 | 69.3% | 35.0% |
| 营业利润率 | 22.7% | -39.6% |
| 净利率 | — | -34.9% |
| 营收同比 | 27.7% | 77.4% |
| 净利润同比 | — | -74.8% |
| 每股收益（稀释后） | $0.26 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITLS
| Q4 25 | $75.5M | $46.8M | ||
| Q3 25 | $54.5M | $51.4M | ||
| Q2 25 | $52.4M | $36.0M | ||
| Q1 25 | $46.0M | $30.6M | ||
| Q4 24 | $59.1M | $26.4M | ||
| Q3 24 | $80.5M | $23.8M | ||
| Q2 24 | $47.1M | $28.5M | ||
| Q1 24 | $43.8M | $29.6M |
净利润PBYITLS
| Q4 25 | — | $-16.3M | ||
| Q3 25 | $8.8M | $-2.1M | ||
| Q2 25 | $5.9M | $-9.5M | ||
| Q1 25 | $3.0M | $-8.6M | ||
| Q4 24 | — | $-9.3M | ||
| Q3 24 | $20.3M | $-28.1M | ||
| Q2 24 | $-4.5M | $-7.8M | ||
| Q1 24 | $-4.8M | $-7.4M |
毛利率PBYITLS
| Q4 25 | 69.3% | 35.0% | ||
| Q3 25 | 77.7% | 39.9% | ||
| Q2 25 | 76.5% | 33.2% | ||
| Q1 25 | 77.1% | 39.8% | ||
| Q4 24 | 76.4% | 40.3% | ||
| Q3 24 | 63.9% | 13.2% | ||
| Q2 24 | 77.4% | 34.1% | ||
| Q1 24 | 75.5% | 37.0% |
营业利润率PBYITLS
| Q4 25 | 22.7% | -39.6% | ||
| Q3 25 | 17.6% | -4.8% | ||
| Q2 25 | 12.7% | -27.5% | ||
| Q1 25 | 8.7% | -29.5% | ||
| Q4 24 | 22.6% | -37.6% | ||
| Q3 24 | 27.4% | -121.4% | ||
| Q2 24 | -4.6% | -30.3% | ||
| Q1 24 | -5.3% | -28.5% |
净利率PBYITLS
| Q4 25 | — | -34.9% | ||
| Q3 25 | 16.2% | -4.1% | ||
| Q2 25 | 11.2% | -26.5% | ||
| Q1 25 | 6.5% | -28.1% | ||
| Q4 24 | — | -35.4% | ||
| Q3 24 | 25.2% | -118.0% | ||
| Q2 24 | -9.6% | -27.2% | ||
| Q1 24 | -11.0% | -24.9% |
每股收益（稀释后）PBYITLS
| Q4 25 | $0.26 | $-0.22 | ||
| Q3 25 | $0.17 | $-0.03 | ||
| Q2 25 | $0.12 | $-0.13 | ||
| Q1 25 | $0.06 | $-0.12 | ||
| Q4 24 | $0.40 | $-0.13 | ||
| Q3 24 | $0.41 | $-0.39 | ||
| Q2 24 | $-0.09 | $-0.11 | ||
| Q1 24 | $-0.10 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $53.2M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $96.0M |
| 总资产 | $216.3M | $139.9M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITLS
| Q4 25 | $97.5M | $53.2M | ||
| Q3 25 | $94.4M | $59.0M | ||
| Q2 25 | $96.0M | $57.0M | ||
| Q1 25 | $93.2M | $57.8M | ||
| Q4 24 | $101.0M | $54.6M | ||
| Q3 24 | $96.7M | $69.8M | ||
| Q2 24 | $96.8M | $80.1M | ||
| Q1 24 | $107.2M | $93.9M |
总债务PBYITLS
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYITLS
| Q4 25 | $130.3M | $96.0M | ||
| Q3 25 | $115.3M | $119.7M | ||
| Q2 25 | $104.7M | $118.4M | ||
| Q1 25 | $97.1M | $126.1M | ||
| Q4 24 | $92.1M | $127.1M | ||
| Q3 24 | $71.1M | $129.5M | ||
| Q2 24 | $48.5M | $149.1M | ||
| Q1 24 | $51.0M | $154.4M |
总资产PBYITLS
| Q4 25 | $216.3M | $139.9M | ||
| Q3 25 | $202.9M | $164.3M | ||
| Q2 25 | $194.9M | $165.0M | ||
| Q1 25 | $196.2M | $158.1M | ||
| Q4 24 | $213.3M | $158.2M | ||
| Q3 24 | $220.7M | $166.3M | ||
| Q2 24 | $205.0M | $182.4M | ||
| Q1 24 | $214.1M | $195.4M |
负债/权益比PBYITLS
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $8.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $8.0M |
| 自由现金流率自由现金流/营收 | 19.1% | 17.0% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $29.4M |
8季度趋势，按日历期对齐
经营现金流PBYITLS
| Q4 25 | $14.4M | $8.0M | ||
| Q3 25 | $9.7M | $9.1M | ||
| Q2 25 | $14.1M | $7.0M | ||
| Q1 25 | $3.6M | $6.1M | ||
| Q4 24 | $15.6M | $-10.5M | ||
| Q3 24 | $11.0M | $-7.1M | ||
| Q2 24 | $1.0M | $-8.0M | ||
| Q1 24 | $11.2M | $-350.0K |
自由现金流PBYITLS
| Q4 25 | $14.4M | $8.0M | ||
| Q3 25 | $9.7M | $8.7M | ||
| Q2 25 | $14.1M | $6.8M | ||
| Q1 25 | $3.6M | $6.0M | ||
| Q4 24 | $15.6M | $-12.4M | ||
| Q3 24 | $11.0M | $-7.1M | ||
| Q2 24 | $1.0M | $-8.2M | ||
| Q1 24 | — | $-447.0K |
自由现金流率PBYITLS
| Q4 25 | 19.1% | 17.0% | ||
| Q3 25 | 17.7% | 16.9% | ||
| Q2 25 | 26.8% | 19.0% | ||
| Q1 25 | 7.7% | 19.5% | ||
| Q4 24 | 26.4% | -47.0% | ||
| Q3 24 | 13.7% | -30.0% | ||
| Q2 24 | 2.1% | -28.9% | ||
| Q1 24 | — | -1.5% |
资本支出强度PBYITLS
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.0% | 7.1% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.0% | 0.3% |
现金转化率PBYITLS
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
